FDA Calls Novartis' Melanoma Combo Drug a Breakthrough Post author:Sam Post published:October 22, 2017 Post category:BioPharma The FDA based its decision on data from the COMBI-AD Phase III trial. Source: BioSpace You Might Also Like <b>Synergy Radiology Associates</b> Radiologists Using Hi-Tech, 3-D Imaging For Better Prostate Cancer Diagnosis, Less Worry July 11, 2017 Reckitt Benckiser to Lay Off 140 Employees in Missouri February 8, 2017 Clarus Ventures Wants To Pick Up The Tab For Big Pharma's R&D With New $910 Million Fund July 17, 2017
<b>Synergy Radiology Associates</b> Radiologists Using Hi-Tech, 3-D Imaging For Better Prostate Cancer Diagnosis, Less Worry July 11, 2017
Clarus Ventures Wants To Pick Up The Tab For Big Pharma's R&D With New $910 Million Fund July 17, 2017
